A Controlled Trial of Plasmapheresis Therapy in Severe Lupus Nephritis

Authors:
  • FGfor the Lupus Nephritis Collaborative Study Group*
    for the Lupus Nephritis Collaborative Study Group*
Publisher website
Google Scholar
Abstract
The prognosis of patients with systemic lupus erythematosus who have glomerulonephritis is poor, despite treatment with immunosuppressive therapy. Plasmapheresis therapy has been used, but there have been few controlled clinical observations of its efficacy.

This publication has 21 references indexed in Scilit: